MMG
RDHL

Monetary Management Group’s Redhill Biopharma RDHL Stock Holding History

Monetary Management Group’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3
Closed -$32K – 311
2017
Q3 		$32K Hold
3
– – 0.01% 245
2017
Q2 		$26K Hold
3
– – 0.01% 252
2017
Q1 		$29K Hold
3
– – 0.01% 243
2016
Q4 		$31K Hold
3
– – 0.01% 253
2016
Q3 		$42K Hold
3
– – 0.02% 234
2016
Q2 		$33K Hold
3
– – 0.02% 254
2016
Q1 		$37K Sell
3
-1
-25% -$10.5K 0.02% 244
2015
Q4 		$50K Hold
4
– – 0.02% 226
2015
Q3 		$50K Hold
4
– – 0.03% 228
2015
Q2 		$69K Hold
4
– – 0.03% 221
2015
Q1 		$57K Hold
4
– – 0.03% 249
2014
Q4 		$52K Hold
4
– – 0.02% 254
2014
Q3 		$58K Hold
4
– – 0.03% 246
2014
Q2 		$77K Buy
+4
New +$63.5K 0.04% 219

Other funds holding RDHL

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Monetary Management Group's RDHL Position: Q4 2017 in Review

Monetary Management Group sold out of Redhill Biopharma (RDHL) in Q4 2017, closing a stake of 3 shares — an estimated $32K sold.

Monetary Management Group first reported a position in RDHL in Q2 2014 and held it in 14 quarters. The position peaked at $77K in Q2 2014. 31 funds tracked by Wall St. Rank hold RDHL as of Q4 2017.

  • Monetary Management Group reported no remaining Redhill Biopharma position as of Q4 2017 after selling out during the quarter.
  • Monetary Management Group sold 3 Redhill Biopharma shares in Q4 2017, an estimated $32K.
  • Monetary Management Group first reported a position in Redhill Biopharma in Q2 2014 and held it in 14 quarters.
  • Monetary Management Group's Redhill Biopharma position peaked at $77K in Q2 2014.
  • 31 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2017.

Based on Monetary Management Group's 13F filing for Q4 2017, filed 14 Feb 2018.